Keyrus Life Science

What Keyrus Life Science does

Keyrus Life Science is a France-based clinical research and development organization founded in 1998 and headquartered in Levallois-Perret. The company operated as a subsidiary of the Keyrus strategic operating group, focusing on clinical research organization (CRO) services and broader life science activities for clients in the pharmaceutical and healthcare sectors. Its business model historically centered on service-based CRO engagements, leveraging the distribution and operational platform of its parent organization.

Input data provides no detailed product catalog, pricing model, customer segmentation, or technology stack disclosures. The available record consists almost entirely of a corporate maintenance notice at keyruslifescience.com that redirects visitors: life science activity is referred to the parent brand at Keyrus.com, while the former KLS – CRO activity is referred to Alsinova.com. This indicates a material restructuring of the entity, with the CRO line separated and the life science activity consolidated under the parent. The current operating status, product offering, and revenue mechanics of the residual Keyrus Life Science entity are not disclosed in source material.

Leadership data is limited to a single disclosed role: Christophe Severs, Head of Department, head of strategy. The entity is private with no disclosed funding rounds, M&A activity, regulatory actions, or strategic partnerships in the input set. Given the maintenance page redirects and absence of operational detail, the residual entity appears to be in a transitional or reduced-operations posture within the broader Keyrus group.

Name

Keyrus Life Science

Legal name

Keyrus Life Science

Website

https://keyruslifescience.com

Company type

Private

Founded year

1998

Operating status

Closed

Headcount range

251–500 employees

Short description

Keyrus Life Science is a France-based clinical research and development organization founded in 1998 as a subsidiary of Keyrus, providing CRO and life science services to pharmaceutical and healthcare clients. Its website is under maintenance, with CRO activity redirected to Alsinova and remaining life science activity to the parent Keyrus.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG) (HLAGAAAJ)

akta.pro secondary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Clinical research services
• Contract research organization
• Biostatistics services
• Life science consulting
• Clinical data management

Headquarters

HQ city

Levallois-perret

HQ country

France

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

Keyrus Life Science is a clinical research and development organization providing CRO and life science services to pharmaceutical and biotechnology clients. According to the maintenance notice, the life science activity of Keyrus is now referenced at www.Keyrus.com, and the former KLS–CRO activity has been redirected to www.Alsinova.com.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights1 record

Direct peers

• Medpace: Medpace is a mid-sized, full-service clinical CRO with strong European operations, closely comparable to the scale and clinical R&D focus that Keyrus Life Science historically offered.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with strong European and North American presence, offering comparable full-service clinical development support to mid-tier biopharma sponsors.
• Alsinova: Alsinova is the entity to which Keyrus Life Science's former CRO activity has been redirected, making it the most directly comparable peer and effectively the successor of KLS's clinical research operations.
• Parexel: Parexel is a global CRO providing clinical trial, regulatory, and market access services to biopharma, comparable in service mix to a full-service CRO like the former KLS.

Broad incumbents

• Keyrus: Keyrus is the strategic parent company of Keyrus Life Science and operates broadly in data, digital, and consulting services. It is the natural parent-level reference point for understanding KLS's positioning and potential cross-sell opportunities.
• Labcorp Drug Development (formerly Covance): Labcorp's drug development segment offers central laboratory and clinical trial services globally, directly comparable to the CRO activity that KLS previously ran before it was redirected to Alsinova.
• Charles River Laboratories: Charles River provides preclinical and clinical CRO services plus manufacturing support to biopharma, representing an established comparable for the life science services side of the Keyrus group.
• ICON plc: ICON is a major global CRO offering clinical trial management, laboratory, and consulting services to biopharma, comparable in scope to a full-service CRO like Keyrus Life Science historically operated.
• IQVIA: IQVIA is a global leader in clinical research services and life science informatics, providing CRO, real-world evidence, and clinical trial technology — overlapping directly with the historical KLS CRO and informatics footprint.

Emerging players

• Veeva Systems: Veeva provides cloud-based clinical trial informatics (CTMS, eTMF, EDC) and life sciences CRM, representing the software side of the clinical R&D value chain that KLS's clinical operations would have relied on or competed against.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/keyrus-lifescience

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Keyrus Life Science